Italian Multiple Sclerosis Foundation Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2001
NCT00202410
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Italian Multiple Sclerosis Association and Foundation | Italian Multiple Sclerosis Foundation